Gateway Advisory’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Gateway Advisory’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,812	Closed	-$455K	–	42
2015 Q2	$455K	Hold	7,812	–	–	0.2%	31
2015 Q1	$449K	Sell	7,812 -225	-3%	-$12.3K	0.2%	29
2014 Q4	$406K	Hold	8,037	–	–	0.18%	29
2014 Q3	$376K	Buy	8,037 +27	+0.3%	+$1.22K	0.17%	32
2014 Q2	$361K	Hold	8,010	–	–	0.17%	33
2014 Q1	$338K	Buy	8,010 +240	+3%	+$10.1K	0.16%	35
2013 Q4	$306K	Buy	+7,770	New	+$292K	0.17%	34

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Gateway Advisory's IHE Position: Q3 2015 in Review

Gateway Advisory sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 7,812 shares — an estimated $455K sold.

Gateway Advisory first reported a position in IHE in Q4 2013 and held it in 7 quarters. The position peaked at $455K in Q2 2015. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

Gateway Advisory reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Gateway Advisory sold 7,812 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $455K.
Gateway Advisory first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 7 quarters.
Gateway Advisory's iShares US Pharmaceuticals ETF position peaked at $455K in Q2 2015.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on Gateway Advisory's 13F filing for Q3 2015, filed 6 Nov 2015.